Apart from this direct effect of adenosine on effector T cells, our previous study also showed that CD39+ Treg from colon cancer patients have the ability to suppress transendothelial migration of conventional T cells, affecting anti-tumor immunity in yet another way [9]. This evidence concerns the gene ENTPD1 and malignant colon neoplasm.